Tariff-Proof But Not China-Proof: The Geopolitics of India’s Pharma Power

Дата публикации: 26-06-2026 14:16:00

Washington has spared India’s generics from its new drug tariffs. But the real exposure running through India’s pharmacy lies upstream, in China – and it is the West’s problem too.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	The Industrial Gap in India-Japan Economic Security	-2	6	30-06-2026
2	Loyalty Without Leverage: India’s US Tilt Yields Little	-2	6	23-06-2026
3	India Will Not Become Another China	-2	6	22-05-2026
4	Chinese Surveillance Cameras Have Become a Huge Problem for India	-5	6	17-06-2026
5	India’s Drone Production Ecosystem Is Evolving	-3	6	26-06-2026
6	Why India Does Not Interest China	-3	4	16-06-2026
7	India’s Critical Mineral Challenge in a New Global Resource Order	0	5	25-06-2026
8	India-US Relations: Too Important to Fail, Too Complicated to Trust	0	5	17-06-2026
9	Why India Cannot Let the Rupee Float	-2	6	02-06-2026
10	CNBC's Inside India newsletter: Why an India-U.K. trade deal does not make U.S.-India agreement any easier	0	5	31-07-2025

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7. Источник: thediplomat.com.